About this document
Colchicine by peeaar30 is a document available to read on EtoBox.
This systematic review and meta-analysis evaluated the efficacy and safety of low-dose colchicine in patients with atherosclerotic cardiovascular disease (ASCVD), involving 11 trials and 30,808 participants. Colchicine was associated with a 17% reduction in major adverse cardiovascular events (MACE) and a 23% reduction in extended MACE, primarily driven by lower rates of myocardial infarction and coronary revascularization, although it did not significantly affect mortality rates. Further research is needed
- Author
- peeaar30
- Language
- EN